Quantum Biopharma
Nasdaq QNTM · Toronto, Ontario, Canada
Works in Immunology · Infectious disease · Psychiatry · Respiratory
Quantum Biopharma is a clinical trial sponsor based in Toronto, Ontario, Canada, listed as Nasdaq QNTM. It has no active clinical trials as lead sponsor; its trials since 2021 were in Immunology, Infectious disease, Psychiatry and Respiratory. Since 2021 it has completed 2 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq QNTM
Fundraising
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Quantum Biopharma
Quantum Biopharma has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 2 trials and stopped 2 early.
Quantum Biopharma is based in Toronto, Ontario, Canada and is listed as Nasdaq QNTM. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Quantum Biopharma; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-04-21.
Approve Suite is not affiliated with Quantum Biopharma.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.